Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Weakening fundamentals in 2008 and projected for 2009 dampen the outlook for pharmaceutical chemical outsourcing, but near-term growth and investments levels in R&D and capital spending remain fairly robust.

Outlook for Custom Manufacturing is Mixed

Gilles Cottier, SAFC's new president, plans to continue a growth strategy that emphasizes value-added technologies positions, growth in Asia, and customization in its supply-chain solutions.

SAFC New President Outlines Growth Strategies

FDA issued a notice in the Federal Register last week requesting comments on the automated collection of four additional pieces of information that are not available in the US Customs and Border Protection's (CBP) data set.

FDA Wants More Automation for Select Import Information

Also, Schering-Plough's vaccine unit, Nobilon, formed an agreement with the World Health Organization; Ore Pharmaceuticals named president and CEO; more...

Company and People Notes: Elan Announces Restructuring; Von Eschenbach Joins Greenleaf Health; More...

The authors investigate the effects of a polyethylene glycol plasticizer and water on cellulose acetate film properties.

Formulation Effects on the Thermomechanical Properties and Permeability of Free Films and Coating Films: Characterization of Cellulose Acetate Films

Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process to keep pharma moving forward.

Critical Challenges Require Core Values

Brief pharmaceutical news items for March 2009.

Pharma Capsules

Contract manufacturers of APIs and intermediates report gains, but express caution.

API Outsourcing is Mixed

Contract manufacturers deploy a business model using operations in the US and Western Europe with facilities in Asia.

Narrowing the Geographic Divide in API Sourcing

Also, GPC Biotech AG and Agennix to merge; BASi appoints COO of scientific services; more...

Ingredients